61504-119-05 : NDC 2026 Code

61504-119-05 : Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride ( Severe Sinus Relief )

Additionally :

You can get information about “61504-119-05” NDC code in 61504-119-05 in HTML format

HTML | 61504-119-05 in TXT (Plain Text) format

TXT | 61504-119-05 in PDF (Portable Document Format)

PDF | 61504-119-05 in XML format

XML formats.

NDC Code : 61504-119-05 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "61504-119-05",
    "PackageDescription": "2 BLISTER PACK in 1 CARTON (61504-119-05)  / 12 TABLET, COATED in 1 BLISTER PACK",
    "NDC11Code": "61504-0119-05",
    "ProductNDC": "61504-119",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Severe Sinus Relief",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride",
    "DosageFormName": "TABLET, COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20231030",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "AMERIFOODS TRADING COMPANY",
    "SubstanceName": "ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE",
    "StrengthNumber": "325; 200; 5",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2024-12-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20241231",
    "StartMarketingDatePackage": "20231030",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}